The Prognostic Value of C‐Reactive Protein‐Albumin‐Lymphocyte (CALLY) Index in Predicting In‐Hospital Mortality After Primary Percutaneous Coronary Intervention in Patients With ST‐Elevation Myocardial Infarction (STEMI)
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.31623 ↗Kurz gefasst
Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Yusuf Demir und 1 weiteren Autor:innen. Beteiligte Einrichtung: Bakircay University Cigli Training and Research Hospital, İzmir, Turkey. Hauptthemen laut MEDLINE: Hospital Mortality, Percutaneous Coronary Intervention, ST Elevation Myocardial Infarction, C-Reactive Protein. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Background
The C‐reactive protein‐albumin‐lymphocyte (CALLY) index is a clinically feasible biomarker for cancer prognosis. CALLY index and post‐primary percutaneous coronary intervention (pPCI) in‐hospital mortality in patients with ST‐elevation myocardial infarction (STEMI) remains unclear, despite evidence showing the predictive value of the CALLY index in various cancers.
Aims
This study aims to examine the relationship between the CALLY index assessed at hospital admission and in‐hospital mortality in STEMI patients.
Methods
The population for this retrospective study comprised 1423 consecutive patients diagnosed with STEMI who underwent pPCI. Out of these, 1133 patients were selected for the study sample and were divided into two groups based on the median CALLY index value of 3.03. In‐hospital mortality rates during the follow‐up period were obtained from the registry.
Results
The study's primary outcome, that is, in‐hospital mortality, was significantly higher in patients with a CALLY index ≤ 6.15 than in those with a CALLY index > 6.15 (38 [6.7%] vs. 7 [1.2%], p < 0.001). Univariate and multivariate Cox proportional hazard analyses revealed that the CALLY index is independently associated with in‐hospital mortality. CALLY index optimal cut‐off value of ≤ 3.03 predicted in‐hospital mortality with 75.5% sensitivity and 78.2% specificity.
Conclusion
This study's findings indicate that the CALLY index may be a significant independent predictor of in‐hospital mortality in patients with STEMI treated with pPCI. Those with a lower CALLY index are at a higher risk of experiencing in‐hospital mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bakircay University Cigli Training and Research Hospital, İzmir, Turkey.
- Department of Cardiology, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training Research Hospital, Istanbul, Turkey.
ORCID-Profile: Yusuf Demir, Samet Sevinc
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Demir, Y., & Sevinc, S. (2025). The Prognostic Value of C‐Reactive Protein‐Albumin‐Lymphocyte (CALLY) Index in Predicting In‐Hospital Mortality After Primary Percutaneous Coronary Intervention in Patients With ST‐Elevation Myocardial Infarction (STEMI). Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31623
Vancouver
Demir Y, Sevinc S. The Prognostic Value of C‐Reactive Protein‐Albumin‐Lymphocyte (CALLY) Index in Predicting In‐Hospital Mortality After Primary Percutaneous Coronary Intervention in Patients With ST‐Elevation Myocardial Infarction (STEMI). Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31623
BibTeX
@article{Demir2025,
author = {Demir, Yusuf and Sevinc, Samet},
title = {The Prognostic Value of C‐Reactive Protein‐Albumin‐Lymphocyte (CALLY) Index in Predicting In‐Hospital Mortality After Primary Percutaneous Coronary Intervention in Patients With ST‐Elevation Myocardial Infarction (STEMI)},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.31623}
}
EUVIMED